Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

QDEL

QuidelOrtho (QDEL)

QuidelOrtho Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:QDEL
日付受信時刻ニュースソース見出しコード企業名
2024/05/1018 : 45PR Newswire (US)Investors in QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact The Gross Law Firm Before June 11, 2024 to Discuss Your Rights - QDELNASDAQ:QDELQuidelOrtho Corporation
2024/05/0905 : 07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QDELQuidelOrtho Corporation
2024/05/0905 : 05Business WireQuidelOrtho Reports First Quarter 2024 Financial ResultsNASDAQ:QDELQuidelOrtho Corporation
2024/05/0805 : 14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QDELQuidelOrtho Corporation
2024/05/0719 : 05PR Newswire (US)Investors who lost money on QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) should contact The Gross Law Firm about pending Class Action - QDELNASDAQ:QDELQuidelOrtho Corporation
2024/05/0318 : 45PR Newswire (US)Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:QDELQuidelOrtho Corporation
2024/05/0221 : 00Business WireQuidelOrtho Appoints Brian J. Blaser as President and Chief Executive OfficerNASDAQ:QDELQuidelOrtho Corporation
2024/04/2618 : 45PR Newswire (US)QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - QDELNASDAQ:QDELQuidelOrtho Corporation
2024/04/1919 : 40PR Newswire (US)Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) - June 11, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:QDELQuidelOrtho Corporation
2024/04/1720 : 00Business WireQuidelOrtho To Report First Quarter 2024 Financial ResultsNASDAQ:QDELQuidelOrtho Corporation
2024/04/1020 : 00Business WireQuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership AssayNASDAQ:QDELQuidelOrtho Corporation
2024/04/0222 : 00Business WireQuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 TestNASDAQ:QDELQuidelOrtho Corporation
2024/03/0706 : 35Business WireQuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in CanadaNASDAQ:QDELQuidelOrtho Corporation
2024/03/0106 : 40Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:QDELQuidelOrtho Corporation
2024/03/0105 : 29Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:QDELQuidelOrtho Corporation
2024/02/2706 : 30Business WireQuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor ConferenceNASDAQ:QDELQuidelOrtho Corporation
2024/02/2121 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QDELQuidelOrtho Corporation
2024/02/2121 : 30Business WireQuidelOrtho Announces Changes in Executive LeadershipNASDAQ:QDELQuidelOrtho Corporation
2024/02/1706 : 08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QDELQuidelOrtho Corporation
2024/02/1706 : 07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QDELQuidelOrtho Corporation
2024/02/1621 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QDELQuidelOrtho Corporation
2024/02/1406 : 07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QDELQuidelOrtho Corporation
2024/02/1406 : 05Business WireQuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:QDELQuidelOrtho Corporation
2024/02/1311 : 44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QDELQuidelOrtho Corporation
2024/02/1311 : 43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QDELQuidelOrtho Corporation
2024/02/0310 : 08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QDELQuidelOrtho Corporation
2024/01/2321 : 00Business WireQuidelOrtho to Report Fourth Quarter and Full-year 2023 Financial ResultsNASDAQ:QDELQuidelOrtho Corporation
2023/12/2221 : 00Business WireQuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:QDELQuidelOrtho Corporation
2023/12/2106 : 05Business WireQuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR AssayNASDAQ:QDELQuidelOrtho Corporation
2023/12/0906 : 14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:QDELQuidelOrtho Corporation
 Showing the most relevant articles for your search:NASDAQ:QDEL

最近閲覧した銘柄